Tauber Helmuth, Streif Werner, Fritz Josef, Ott Helmut, Weigel Guenter, Loacker Lorin, Heinz Anneliese, Velik-Salchner Corinna
Departments of Anaesthesiology and Critical Care Medicine.
Pediatrics and Adolescent Medicine.
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):692-701. doi: 10.1053/j.jvca.2016.01.009. Epub 2016 Jan 11.
Patients requiring extracorporeal membrane oxygenation (ECMO) have a well-known bleeding risk and the potential for experiencing possibly fatal thromboembolic complications. Risk factors and predictors of transfusion requirements during ECMO support remain uncertain. The authors hypothesized that compromised organ function immediately before ECMO support will influence transfusion requirements.
A prospective observational study.
A tertiary, single-institutional university hospital.
The study included 40 adult patients requiring ECMO for intractable cardiac and respiratory failure between July 2010 and December 2012. Blood samples were taken before initiation of ECMO (baseline), after 24 and 48 hours on ECMO, and 24 hours after termination of ECMO.
None.
Independent of veno-arterial or veno-venous support, 26% of patients required≥2 packed red blood cells per day (PRBC/d) and 74% of patients required<2 PRBC/d during ECMO. Requirements of≥2 PRBC/d during ECMO support were associated with higher creatinine levels and lower prothrombin times (PT, %) at baseline and with impaired platelet function after 24 hours on ECMO. Platelet function, activated by thrombin receptor-activating peptide stimulation, decreased by 30% to 40% over time on ECMO. Receiver operating characteristic curve analysis showed cut-off values for creatinine of 1.49 mg/dL (sensitivity 70%, specificity 70%; area under the curve [AUC] 0.76, 95% confidence interval [CI] 0.58-0.94), for PT of 48% (sensitivity 80%, specificity 59%; AUC 0.69, 95% CI 0.50-0.87), and for thrombin receptor-activating peptide (TRAP) 32 U (sensitivity 90%, specificity 68%; AUC 0.76, 95% CI 0.59-0.93).
The results of this study demonstrated that increased creatinine levels and lower PT before ECMO and secondary impaired platelet function significantly increased transfusion requirement.
需要体外膜肺氧合(ECMO)的患者存在众所周知的出血风险以及发生可能致命的血栓栓塞并发症的可能性。ECMO支持期间输血需求的风险因素和预测指标仍不明确。作者推测,在ECMO支持前器官功能受损会影响输血需求。
一项前瞻性观察性研究。
一家三级单机构大学医院。
该研究纳入了2010年7月至2012年12月期间40例因顽固性心脏和呼吸衰竭需要ECMO的成年患者。在开始ECMO前(基线)、ECMO治疗24小时和48小时后以及ECMO终止后24小时采集血样。
无。
无论采用静脉-动脉还是静脉-静脉支持,26%的患者在ECMO期间每天需要≥2单位浓缩红细胞(PRBC/d),74%的患者需要<2 PRBC/d。ECMO支持期间≥2 PRBC/d的需求与基线时较高的肌酐水平和较低的凝血酶原时间(PT,%)以及ECMO治疗24小时后血小板功能受损有关。经凝血酶受体激活肽刺激后激活的血小板功能在ECMO期间随时间下降30%至40%。受试者工作特征曲线分析显示,肌酐的截断值为1.49 mg/dL(敏感性70%,特异性70%;曲线下面积[AUC] 0.76,95%置信区间[CI] 0.58 - 0.94),PT为48%(敏感性80%,特异性59%;AUC 0.69,95% CI 0.50 - 0.87),凝血酶受体激活肽(TRAP)为32 U(敏感性90%,特异性68%;AUC 0.76,95% CI 0.59 - 0.93)。
本研究结果表明,ECMO前肌酐水平升高、PT降低以及继发性血小板功能受损显著增加了输血需求。